Placental/umbilical cord blood transplantation

Haematologica

Volumn 84, Issue 8, 1999, Pages 738-747

  Sirchia, Girolamo ^a   Rebulla, Paolo ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Bone marrow transplantation; Placental blood; Umbilical cord blood

Indexed keywords

BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; INTERMETHOD COMPARISON; MONONUCLEAR CELL; REVIEW; STEM CELL; UMBILICAL CORD BLOOD;

ADULT; FETAL BLOOD; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 0032833743     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Gratwohl A, Hermans J, Baldomero H, et al. Indications for haemopoietic precursors cell transplant in Europe. Br J Haematol 1996; 92:35-43.
2. Beatty PG, Kollman C, Howe CWS. Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program. In: Cecka JM, Terasaki PI, eds. Clinical transplants 1995, UCLA Tissue Typing Laboratory, Los Angeles, 1996. p. 271-7.
3. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85:3005-20.
4. Carreras E, Bertz H, Arcese W, et al. Incidence and outcome of hepatic veno-occlusive disease after blood and marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Blood 1998; 92:3599-604.
5. Kantrow SP, Hackman RC, Boeckh M, et al. Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation. Transplantation 1997; 63:1079-86.
6. Schriber JR, Herzig GP. Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Hematol 1997; 34:126-33.
7. Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328:593.
8. Ochs LA. Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation. Bone Marrow Transplant 1994; 13:455-60.
9. Weisdorf DJ, Snover DC, Haake RJ. Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. Blood 1990; 76:624-8.
10. Wingard JR. Advances in the management of infectious complications after bone marrow transplantation. Bone Marrow Transplant 1990; 6:371-83.
11. Zaia J. Viral infections with bone marrow transplantation. Hematol Oncol Clin North Am 1990; 4:603-23.
12. Deeg HJ, Socié G. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood 1998; 91:1833-44.
13. Apperley JF, Reddy N. Mechanism and management of treatment-related gonadal failure in recipients with high dose chemoradiotherapy. Blood Rev 1995; 9:93-116.
14. Borgstrom B, Bolme P. Thyroid function in children after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 13:59-64.
15. Cohen A, Van-Lint MT, Uderzo C, et al. Growth in patients after allogeneic bone marrow transplantation for hematological diseases in childhood. Bone Marrow Transplant 1995; 15:343-8.
16. Nakahata T, Ogawa M. Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono and multipotential hemopoietic progenitors. J Clin Invest 1982; 70:1324-8.
17. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989; 86:3828-32.
18. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord-blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174-8.
19. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335:157-66.
20. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord blood transplantation from related and unrelated donors. N Engl J Med 1997; 337:373-81.
21. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 22:1565-77.
22. Gluckman E, Rocha V, Chastang C, on behalf of Eurocord-Cord Blood Transplant Group. Cord blood hematopoietic stem cells: biology and transplantation. Hematology 1998;1-14. American Society of Hematology, Washington, DC, 1998.
23. Locatelli F, Rocha V, Chastang C, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood 1999; 93: 3662-71.
24. Madrigal JA, Cohen SB, Gluckman E, Charron DJ. Does cord blood transplantation result in lower graft-versus-host disease? It takes more than two to tango. Hum Immunol 1997; 56:1-5.
25. Roncarolo MG, Vaccarino E, Saracco P, et al. Immunologic properties of cord blood. In: Broxmeyer HE, ed. Cellular characteristics of cord blood and cord blood transplantation. Bethesda, MD: AABB Press, 1998, pp. 67-81.
26. Cohen SB, Madrigal JA. Immunological and functional differences between cord and peripheral blood. Bone Marrow Transplant 1998; 21:59-12.
27. Cohen SBA, Dominiguez E, Lowdell M, Madrigal JA. The immunological properties of cord blood: overview of current research presented at the 2nd EUROCORD Workshop. Bone Marrow Transplant 1998; 22:S22-5.
28. Garderet L, Dulphy N, Douay C, et al. The umbilical cord blood αβ T-cell repertoire: characteristics of a polyclonal and naive but completely formed repertoire. Blood 1998;91:340-6.
29. Garban F, Ericson M, Roucard C, et al. Detection of empty HLA class II molecules on cord blood B cells. Blood 1996;87:3970-6.
30. min Lee S, Suen Y, Chang L, et al. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-γ, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells. Blood 1996; 88:945-54.
31. Gardiner CM, O'Meara A, Reen DJ. Differential cytotoxicity of cord blood and bone marrow-derived natural killer cells. Blood 1998; 91:207-13.
32. Mayani H, Gutierrez-Rodriguez M, Espinoza L, et al. Kinetics of hematopoiesis in Dexter-type long-term cultures established from human umbilical cord blood cells. Stem Cells 1998; 16:127-35.
33. Lu L, Xiao M, Shen R-N, et al. Enrichment, characterization and responsiveness of single primitive CD34+++ human umbilical cord blood nematopoietic progenitors with high proliferative and replating potential. Blood 1993; 81:41-8.
34. Pettengell R, Luft T, Henschler R, et al. Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood and blood stem cells. Blood 1994; 84:3653-9.
35. Sutherland HJ, Eaves CJ, Eaves AC, et al. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 1989; 74:1563-9.
36. Mayani H, Lansdorp PM. Biology of umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells 1998; 16:153-65.
37. Civin CI, Strauss LC, Brovall C, et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cell. J Immunol 1984; 133:157-65.
38. Huss R. CD34-stem cells as the earliest precursors of hematopoietic progeny. Exp Hematol 1998; 26:1022-3.
39. Kinninburg D, Russel NH. Comparative study of CD34-positive cells and subpopulations in human umbilical cord blood and bone marrow. Bone Marrow Transplant 1993; 12:489-94.
40. Cardoso A, Li M-L, Batard P, et al. Release from quiescence of CD34+CD38-human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci USA 1993; 90:8707-11.
41. Traycoff CM, Abboud MR, Laver J, et al. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Exp Hematol 1994; 22:215-22.
42. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89:10114-8.
43. Hahn T, Shulman LM, Ben-Hur H, et al. Differential responses to fetal, neonatal, and adult myelopoietic progenitors to interferon and tumor necrosis factor. Exp Hematol 1994; 22:114-21.
44. Vormoor J, Lapidot T, Pflumio F, et al. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 1994; 83:2489-97.
45. Lapidot T, Pflumio F, Doedens M, et al. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 1992; 255:1137-9.
46. Wang JCY, Doedens M, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 1997; 89:3919-24.
47. Hogan CJ, Shpall EJ, Mc Nulty O, et al. Engraftment and development of human CD34+-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood 1997; 90:85-96.
48. Greiner DL, Hesselton RA, Shultz LD. SCID mouse models of human stem cell engraftment. Stem Cells 1998; 16:166-77.
49. Zanjani ED, Pallavicini MG, Ascensao JL, et al. Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest 1992; 89:1178-88.
50. Moritz T, Keller DC, Williams DA. Human cord blood cells as targets for gene transfer: potential use in genetic therapies of severe combined immunodeficiency disease. J Exp Med 1993; 178:529-36.
51. Kohn DB, Weinberg KI, Nolta JA, et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1995; 1:1017-23.
52. Denning-Kendall PA, Nicol A, Horsley H, Donaldson C, Bradley B, Hows JM. Is in vitro expansion of human cord blood cells clinically relevant? Bone Marrow Transplant 1998; 21:225-32.
53. Kohler T, Plettig R, Wetzstein W, et al. Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Influences of progenitor enrichment, interference with feeder layers, early-acting cytokines and agitation of culture vessels. Stem Cells 1999; 17:19-24.
54. Collins PC, Miller WM, Papoutsakis ET. Stirred culture of peripheral and cord blood hematopoietic cells offers advantages over traditional static systems for clinically relevant applications. Biotechnol Bioeng 1998; 59:534-43.
55. Kögler G, Callejas J, Sorg RV, Wernet P. An eight-fold ex vivo expansion of long-term culture initiating cells from umbilical cord blood in stirred suspension cultures. Bone Marrow Transplant 1998; 21:548-53.
56. Rice A, Flemming C, Case J, Stevenson J, Gaudry L, Vowels M. Comparative study of the in vitro behavior of cord blood subpopulations after short-term cytokine exposure. Bone Marrow Transplant 1999; 23:211-20.
57. Piacibello W, Sanavio F, Severino F, et al. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34+ cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood 1999; 93: 3736-49.
58. Lazzari L, De Bernardi N, Villa A, et al. Cord blood stem cells expanded ex vivo with TPO, FLT-3, IL-6 and IL-11 and serum-free medium show engrafting potential in NOD/SCID mice [abstract]. Blood 1998; 92:114a(suppl 1, part 1).
59. Stevenson J, Milross C, Collins C, Vowels M, Rice A. Facilitation of human cord blood (CB) engraftment in NOD SCID mice by cytokine-mediated expansion: influence of cytokine combination and culture duradon [abstract]. Blood 1998; 92:114a (suppl 1, part 1)
60. Güenechea G, Segovia JC, Albella B, et al. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells. Blood 1999; 93:1097-105.
61. Jaroscak J, Martin PL, Waters-Pick B, et al. A phase I trial of augmentation of unrelated umbilical cord blood transplantation with ex-vivo expanded cells [abstract]. Blood 1998; 92:646a (suppl 1, part 1)
62. Shpall EJ, Quinones R, Hami L, et al. Transplantation of cancer patients receiving high dose chemotherapy with ex vivo expanded cord blood cells [abstract]. Blood 1998; 92:646a (suppl 1, part 1).
63. Stiff P, Pecora A, Parthasarathy M, et al. Umbilical cord blood transplants in adults using a combination of unexpanded and ex vivo expanded cells: preliminary observations [abstract]. Blood 1998; 92:646a (suppl 1, part 1)
64. Koller MR, Manchel I, Maher RJ, et al. Clinical-scale human umbilical cord blood cell expansion in a novel automated perfusion culture system. Bone Marrow Transplant 1998; 21:653-63.
65. Lazzari L, Corsini C, Curioni L, et al. The Milan Cord Blood Bank and the Italian Cord Blood network. J Hematother 1996; 5:117-22.
66. Sirchia G, Rebulla P, Lecchi L, et al. Implementation of a quality system (ISO 9000 Series) for placental blood banking. J Hematother 1998;7:19-35.
67. Armitage S, Fehily D, Dickinson A, et al. Cord blood banking: volume reduction of cord blood units using a semi-automated closed system. Bone Marrow Transplant 1999; 23:505-9.
68. Areman EM, Deeg HJ, Sacher RA, eds. Bone marrow and stem cell processing: a manual of current techniques. Philadelphia: F.A. Davis Co., 1992. p. 292-362.
69. Sirchia G, Rebulla P, Tibaldi S, et al. Cost of umbilical cord blood units released for transplantation. Transfusion 1999; 39:645-50.
70. Wernet P, Sirchia G, Garcia-Lopez J, et al. The international NETCORD organization for high standard cord blood banking [abstract]. Blood 1998; 92:140b (suppl 1, part 2).
71. Fraser JK, Cairo MS, Wagner EL, et al. Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. J Hematother 1998; 7:521-61.
72. Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT). Standards for hematopoietic progenitor cell collection, processing and transplantation, 1996.
73. Gratwohl A, Passweg J, Baldomero H, et al. Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1998; 22:227-40.
74. National Marrow Donor Program. Cord blood: what are the issues? Cord Blood Update 1998; 2:1-2.
75. Locatelli F, Burgio GR. Transplant of hematopoietic stem cells in childhood: where we are and where we are going. Haematologica 1998; 83:550-63.